CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.85 ($9,234)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.84 ($18,400)
- 4 Open-market buy Chief Medical Officer bought 6,000 shares at $1.87 ($11,220)
- 4 Open-market buy Chief Executive Officer bought 550 shares at $1.95 ($1,070)
- 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $2.05 ($20,500)
- 4 Open-market sale 10% owner sold 200,000 shares at $3.04 ($607,760)
- 4 Open-market buy Chief Financial Officer bought 1,400 shares at $2.06 ($2,879)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.92 ($1,916)
- 4 Open-market buy Director bought 8,212 shares at $1.90 ($15,603)
- 4 Open-market buy Chief Medical Officer bought 20,000 shares at an average $1.90 ($37,999)
- 4 Open-market buy Director bought 10,000 shares at an average $1.89 ($18,945)
- 4 Open-market buy Director bought 1,000 shares at $1.92 ($1,919)
- 4 Open-market buy Director bought 1,000 shares at $1.90 ($1,900)
- 4 Open-market buy Director bought 11,788 shares at an average $1.94 ($22,842)
- 4 Open-market buy Chief Executive Officer bought 2,100 shares at an average $1.92 ($4,028)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 17 · 340 filings